LND topic: tme page 59

tme

Why Hamilton Stock Might Be a Smart Pick Right Now

October 25, 2025

Hamilton Stock has been making waves in the insurance sector. It's not just any company; it's a leader in its field. Recently, it has entered a new buy zone. This means it might be a good time to consider investing in it. But why is this significant? Well, the insurance industry is huge. It's all a

finance

Small Raise for Seniors: Will It Be Enough?

October 24, 2025

Next year, seniors and other Social Security beneficiaries will see a small boost in their monthly checks. The increase is 2. 8%, which works out to about $56 more per month for the average person. This change is meant to help with rising costs, but it might not be enough. Health care costs eat up

business

Tech Boosts Baker Hughes' Future, But Oil Investments Lag

October 24, 2025

Baker Hughes is banking on artificial intelligence to drive its future growth. The company is so confident in this tech that it expects to hit $1. 5 billion in data center orders sooner than planned. This is a big deal because it shows how much demand there is for data center power. But it's not al

technology

New Faces at AXS: A Fresh Approach to Ticketing

October 24, 2025

AXS, a big name in ticketing and event tech, has just welcomed two new leaders to its team. Nikhil Bobde is now the chief tech officer, and Alex Hazboun is stepping into a new role as the chief innovation officer. These changes show that AXS is serious about improving its tech and growing bigger. B

health

A New Hope in Fighting Solid Tumors: CDR404 Shows Promise

October 24, 2025

CDR404, a new type of cancer treatment, is making waves in the medical world. This treatment is designed to target specific cancer cells and activate the body's immune system to fight them. Recent studies have shown that CDR404 can trigger a strong immune response in patients with certain types of c

health

A New Hope in Cancer Treatment: Zymeworks' Promising Early Results

October 24, 2025

Zymeworks, a biotech company, has shared positive early results from its phase 1 trial. The trial is for a new drug called ZW-191. This drug is designed to target a specific marker called folate receptor-alpha (FRα) found in many cancer types. The results show that ZW-191 can shrink tumors and is ge

finance

Finding the Right Shield for Green Investments

October 24, 2025

Investing in renewable energy can be a bumpy ride. The ups and downs can be tough on investors. So, what can they do to protect their money? They need safe-haven assets. These are investments that can help reduce risk. Think of them as a shield. Gold and green bonds are strong shields. They can pro

crypto

Bitcoin's Wild Ride: Why Big Drops Are Still Possible

October 24, 2025

Bitcoin's reputation for wild price swings is far from over. Tom Lee, a well-known figure in the crypto world, recently shared his thoughts on the matter. He believes that even with more investors and new financial products, Bitcoin can still drop by half its value. Lee pointed out that Bitcoin oft

business

Tesla's Bitcoin Bet Pays Off in Q3 2025

October 24, 2025

Tesla made a cool $80 million from its Bitcoin stash in the third quarter of 2025. This profit came just from Bitcoin's price going up, not from selling any of it. Tesla still has about 11, 509 BTC, worth around $1. 31 billion as of September 30. That's up from $1. 23 billion in the second quarter. ...

finance

Exploring Vanguard's Global Stock Fund: A Smart Choice?

October 24, 2025

Vanguard's FTSE Developed Markets ETF, or VEA, is a popular pick for investors looking to dip their toes into international stocks. It's like a big basket filled with nearly all the stocks from developed countries outside the U. S. The fund is known for its low fees and wide range of holdings, makin